Last updated 2026-07-26
Total raised
—
Last: Undisclosed Round 2023-06
Stage
Seed
Founded
2019
Headcount
12
HQ
Netanya, Israel
Sector
Health Tech & Life Sciences
About
NanoGhost is an Israeli biotech company that develops a highly selective first-in-class drug delivery platform (Nano-Ghosts/NGs) from the cell membrane of mesenchymal stem cells (MSCs). These NGs are nanovesicles that retain the MSCs' natural ability to target cancer and sites of inflammation, and can be loaded with various drug types (small molecules, DNA, RNA, peptides, proteins). The technology aims to deliver medicine directly to tumor sites, reducing tumor size and prolonging survival, as demonstrated in preclinical models. The NanoGhost technology was developed by Professor Marcelle Machluf at the Technion-Israel Institute of Technology. NanoGhost has received six grants from the Israel Innovation Authority.
Headcount over time
12 employees (2026-09) · 1 point
Offices
Netanya, Israel · HQ / main office
Q&A
- What is NanoGhost's primary focus?
- NanoGhost is a biotech company developing a highly selective first-in-class drug delivery platform for oncological and immunological diseases.
- When was NanoGhost founded?
- NanoGhost was founded in August 2019.
- How much funding has NanoGhost raised in total?
- NanoGhost has raised a total of $17,000,000 USD.
- Which investor participated in NanoGhost's Seed round in December 2019?
- aMoon participated in NanoGhost's Seed round in December 2019.
- What is the employee count for NanoGhost?
- NanoGhost has 11-50 employees.
- Who are the founders of NanoGhost?
- The founders of NanoGhost are Marcelle Machluf and Yonatan Malca.
- What is the core technology behind NanoGhost's platform?
- NanoGhost's platform uses nanovesicles, called Nano-Ghosts (NGs), reconstructed from the cell membranes of mesenchymal stem cells (MSCs) to target cancer and inflammation sites.
- Has NanoGhost received any grants from the Israel Innovation Authority?
- Yes, NanoGhost has received six grants from the Israel Innovation Authority.
Team · 3
Marcelle Machluf
Founder · Founder (PhD), Full Professor and former Dean of the Faculty of Biotechnology and Food Engineering at the Technion - Israel Institute of Technology
Yonatan Malca
Founder · Co-Founder & CEO (MA)
Osnat Bohana Kashtan
VP R&D (PhD, MBA)
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical Biotechnology
Technologies
Materials & SubstancesBiologicalsCells
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Highlights
1 PatentsVerified
Tags
targeted-cancer-therapycancertargeted-therapystem-cellsdrug-deliverynanotechnologyimmunotherapytreatmentspharmaceuticalsbiotechnologygenetics
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | nano-ghost.com/ |
|---|---|
| linkedin.com/company/80018810 |
Identifiers & details
| Legal name | NANOGHOST LTD |
|---|---|
| Former names | Nano Ghosts |
| Founded | 2019-8 |
| Employees (exact) | 12 |
Radar intelligence
Web history (Wayback)
| Domain | nano-ghost.com |
|---|
Certificate / subdomain footprint
| Subdomains | 1 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 516071149 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2019-08-14 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | yes |
| Last annual report | 2023 |
| Active charges / liens | 1 |
| Registry events | 2 — violation (1), charge (1) |
| Registered address | גאון בני 12 נתניה |
Recent registry events
| Date | Event |
|---|---|
| 2026-06-25 | עדכון הפרה |
| 2026-03-08 | רישום שעבוד |